chr8-17937364-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_006197.4(PCM1):āc.327C>Gā(p.Phe109Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000269 in 1,596,552 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00032 ( 1 hom., cov: 32)
Exomes š: 0.00026 ( 1 hom. )
Consequence
PCM1
NM_006197.4 missense
NM_006197.4 missense
Scores
4
7
7
Clinical Significance
Conservation
PhyloP100: 4.13
Genes affected
PCM1 (HGNC:8727): (pericentriolar material 1) The protein encoded by this gene is a component of centriolar satellites, which are electron dense granules scattered around centrosomes. Inhibition studies show that this protein is essential for the correct localization of several centrosomal proteins, and for anchoring microtubules to the centrosome. Chromosomal aberrations involving this gene are associated with papillary thyroid carcinomas and a variety of hematological malignancies, including atypical chronic myeloid leukemia and T-cell lymphoma. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.008425415).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PCM1 | NM_006197.4 | c.327C>G | p.Phe109Leu | missense_variant | 4/39 | ENST00000325083.13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PCM1 | ENST00000325083.13 | c.327C>G | p.Phe109Leu | missense_variant | 4/39 | 1 | NM_006197.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152082Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
49
AN:
152082
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000463 AC: 104AN: 224436Hom.: 0 AF XY: 0.000512 AC XY: 62AN XY: 121110
GnomAD3 exomes
AF:
AC:
104
AN:
224436
Hom.:
AF XY:
AC XY:
62
AN XY:
121110
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000263 AC: 380AN: 1444470Hom.: 1 Cov.: 29 AF XY: 0.000283 AC XY: 203AN XY: 716844
GnomAD4 exome
AF:
AC:
380
AN:
1444470
Hom.:
Cov.:
29
AF XY:
AC XY:
203
AN XY:
716844
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000322 AC: 49AN: 152082Hom.: 1 Cov.: 32 AF XY: 0.000283 AC XY: 21AN XY: 74288
GnomAD4 genome
AF:
AC:
49
AN:
152082
Hom.:
Cov.:
32
AF XY:
AC XY:
21
AN XY:
74288
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
41
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2021 | The c.327C>G (p.F109L) alteration is located in exon 4 (coding exon 2) of the PCM1 gene. This alteration results from a C to G substitution at nucleotide position 327, causing the phenylalanine (F) at amino acid position 109 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D;D;D;.;.
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;.;D;D;D;D;D
REVEL
Benign
Sift
Uncertain
D;.;D;D;D;D;D
Sift4G
Pathogenic
D;D;T;D;D;D;D
Polyphen
0.99
.;.;D;.;.;.;.
Vest4
MutPred
Gain of phosphorylation at S110 (P = 0.1286);Gain of phosphorylation at S110 (P = 0.1286);Gain of phosphorylation at S110 (P = 0.1286);Gain of phosphorylation at S110 (P = 0.1286);Gain of phosphorylation at S110 (P = 0.1286);Gain of phosphorylation at S110 (P = 0.1286);Gain of phosphorylation at S110 (P = 0.1286);
MVP
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at